Taylor Wealth Management Partners’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$3.44M Sell
78,071
-4,313
-5% -$187K 1.95% 23
2022
Q1
$3.29M Sell
82,384
-4,555
-5% -$162K 1.33% 31
2021
Q4
$3.5M Sell
86,939
-715
-0.8% -$26.7K 1.23% 30
2021
Q3
$3.57M Buy
87,654
+2,245
+3% +$93.9K 1.27% 30
2021
Q2
$3.88M Sell
85,409
-1,792
-2% -$79.3K 1.37% 30
2021
Q1
$3.63M Sell
87,201
-1,740
-2% -$79.4K 1.33% 30
2020
Q4
$3.8M Buy
88,941
+2,085
+2% +$74.9K 1.46% 27
2020
Q3
$2.28M Buy
86,856
+1,038
+1% +$28.9K 1.05% 35
2020
Q2
$2.3M Sell
85,818
-2,173
-2% -$49K 1.17% 32
2020
Q1
$1.58M Buy
87,991
+225
+0.3% +$4.27K 0.97% 32
2019
Q4
$1.56M Sell
87,766
-116,323
-57% -$2.01M 0.72% 32
2019
Q3
$3.17M Sell
204,089
-995
-0.5% -$16.4K 1.48% 24
2019
Q2
$3.52M Buy
205,084
+735
+0.4% +$11.9K 1.65% 25
2019
Q1
$3.29M Buy
204,349
+72
+0% +$1.17K 1.64% 24
2018
Q4
$2.99M Sell
204,277
-17,103
-8% -$273K 1.73% 20
2018
Q3
$4.02M Buy
221,380
+905
+0.4% +$15.9K 1.71% 22
2018
Q2
$3.72M Sell
220,475
-195
-0.1% -$3.69K 1.65% 25
2018
Q1
$4.32M Buy
220,670
+58,995
+36% +$1.14M 2.08% 21
2017
Q4
$3.28M Buy
161,675
+1,215
+0.8% +$22.3K 1.39% 29
2017
Q3
$2.79M Sell
160,460
-630
-0.4% -$8.53K 1.24% 33
2017
Q2
$2.06M Sell
161,090
-2,550
-2% -$34.1K 0.93% 38
2017
Q1
$2.12M Sell
163,640
-11,335
-6% -$143K 0.96% 35
2016
Q4
$1.73M Buy
174,975
+46,865
+37% +$513K 0.8% 39
2016
Q3
$1.55M Buy
+128,110
New +$1.31M 0.69% 37

Other funds holding HALO

Taylor Wealth Management Partners's HALO Position: Q2 2022 in Review

Taylor Wealth Management Partners reduced its Halozyme (HALO) stake by 5.2% in Q2 2022, selling an estimated $187K and leaving 78,071 shares worth $3.44M. The position accounts for 1.95% of the portfolio, ranked #23.

Taylor Wealth Management Partners first reported a position in HALO in Q3 2016 and has held it in 24 quarters since. The position peaked at $4.32M in Q1 2018. 368 funds tracked by Wall St. Rank hold HALO as of Q2 2022.

  • Taylor Wealth Management Partners held 78,071 shares of Halozyme worth $3.44M as of Q2 2022.
  • Taylor Wealth Management Partners sold 4,313 Halozyme shares in Q2 2022, an estimated $187K.
  • Halozyme made up 1.95% of Taylor Wealth Management Partners's portfolio in Q2 2022, its #23 holding.
  • Taylor Wealth Management Partners first reported a position in Halozyme in Q3 2016 and has held it in 24 quarters since.
  • Taylor Wealth Management Partners's Halozyme position peaked at $4.32M in Q1 2018.
  • 368 funds tracked by Wall St. Rank held Halozyme as of Q2 2022.

Based on Taylor Wealth Management Partners's 13F filing for Q2 2022, filed 12 Aug 2022.